Protein-Protein Interactions Protein-Protein Interactions

Protein-Protein Interactions

    • 164,99 €
    • 164,99 €

Description de l’éditeur

Michael D. Wendt
Protein-Protein Interactions as Drug Targets

Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics

Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer

John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection

Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus

Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces

Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor

GENRE
Science et nature
SORTIE
2012
26 juin
LANGUE
EN
Anglais
LONGUEUR
280
Pages
ÉDITIONS
Springer Berlin Heidelberg
DÉTAILS DU FOURNISSEUR
Springer Science & Business Media LLC
TAILLE
6
Mo
Disruption of Protein-Protein Interfaces Disruption of Protein-Protein Interfaces
2013
Chemical Epigenetics Chemical Epigenetics
2020
Bioprobes Bioprobes
2017
Molecular Chaperones Molecular Chaperones
2012
Biophysical and Computational Tools in Drug Discovery Biophysical and Computational Tools in Drug Discovery
2021
Cyclized Helical Peptides Cyclized Helical Peptides
2021